Healthcare startup CrossChx is announcing that it has raised $15 million in Series B funding.
The company focuses on what it calls “global patient identification.” That might sound a little arcane, but CrossChx says its technology can improve patient care and prevent identity theft.
Basically, the company ties a patient’s medical records to a single ID. It can then identify possible errors in their records. CrossChx it’s found that more than 10 percent of medical records contain identity-related errors — for example, if someone incorrectly enters a patient’s social security number, that can lead to multiple, incomplete records.
The company also offers a kiosk for hospital lobbies where patients sign in by having their fingerprints scanned.
Founded in 2012 by CEO Sean Lane and President Brad Mascho (pictured
above), CrossChx says it’s deployed in more than 100 hospitals across
eight states, and it has verified more than 2 million patient visits.
With the new funding, it plans to build mobile tools, grow the team from
about 35 to 100, and expand nationally.
The round was led by Khosla Ventures, with participation from previous backer Drive Capital. (Khosla’s Keith Rabois is joining the CrossChx board as an observer.) The company has now raised more than $20 million total.
The company focuses on what it calls “global patient identification.” That might sound a little arcane, but CrossChx says its technology can improve patient care and prevent identity theft.
Basically, the company ties a patient’s medical records to a single ID. It can then identify possible errors in their records. CrossChx it’s found that more than 10 percent of medical records contain identity-related errors — for example, if someone incorrectly enters a patient’s social security number, that can lead to multiple, incomplete records.
The company also offers a kiosk for hospital lobbies where patients sign in by having their fingerprints scanned.
The round was led by Khosla Ventures, with participation from previous backer Drive Capital. (Khosla’s Keith Rabois is joining the CrossChx board as an observer.) The company has now raised more than $20 million total.